Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds.

Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Abstract Text:

    Palladium and platinum complexes with HmtpO (where HmtpO = 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural ocurring nucleobase hypoxanthine) of the types [M(dmba)(PPh 3)(HmtpO)]ClO 4 [dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl; M = Pd or Pt], [Pd(N-N)(C 6F 5)(HmtpO)]ClO 4 [ N- N = 2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me 2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C 6F 5) 2(HmtpO) 2] (M = Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C 6F 5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu 4] 2[M(C 6F 5) 2(micro-mtpO)] 2 (M = Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu 4][M(C 6F 5) 2(HmtpO)(mtpO)] (M = Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)] (+), cis-[Pt(C 6F 5) 2(HmtpO) 2].acetone, [Pd(C 6F 5)(tmeda)(mtpO)].2H 2O, [Pd(dmba)( micro-mtpO)] 2, [NBu 4] 2[Pd(C 6F 5) 2(micro-mtpO)] 2.CH 2Cl 2.toluene, [NBu 4] 2[Pt(C 6F 5) 2(micro-mtpO)] 2.0.5(toluene), and [NBu 4][Pt(C 6F 5) 2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC 50 were calculated for the new platinum complexes cis-[Pt(C 6F 5) 2(HmtpO) 2] and [Pt(dmba)(PPh 3)(HmtpO)]ClO 4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C 6F 5) 2(HmtpO) 2] and [Pt(dmba)(PPh 3)(HmtpO)]ClO 4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.

    Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Inorganic chemistry

    VOLUME: 47

    Page Numbers: 4490-505

    Journal Abbreviation:

    ISSN: 0020-1669

    DAY: 30

    MONTH: 04

    YEAR: 2008

    Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 366543

    Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Palladium(II) and Platinum(II) Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor Activity of the Platinum Compounds.

    AFFILIATION: Departamento de Química Inorgánica, Universidad de Murcia, E-30071- Murcia, Spain, jruiz@um.es.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Inorg Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    PalladiumII and PlatinumII Organometallic Complexes with 4,7-dihydro-5-methyl-7-oxo1,2,4triazolo1,5-apyrimidine Antitumor Activity of the Platinum Compounds Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News